Literature DB >> 8992887

Doubling skeletal mass during adult life: the syndrome of diffuse osteosclerosis after intravenous drug abuse.

M P Whyte1, S L Teitelbaum, W R Reinus.   

Abstract

A former intravenous substance abuser, seropositive for hepatitis C virus infection, was referred for diffuse osteosclerosis. There was no history of fracture or skeletal deformity. Cortical and trabecular bone density was approximately twice the mean value for controls. Skeletal histology revealed dense lamellar bone. Recognized causes of acquired generalized osteosclerosis or hyperostosis were excluded. This patient verifies the syndrome of painful diffuse osteosclerosis after intravenous drug abuse and shows that skeletal mass can be markedly increased with histologically normal, structurally sound bone during adult life. Elucidation of the etiology and pathogenesis could offer an effective treatment for osteoporosis.

Entities:  

Mesh:

Year:  1996        PMID: 8992887     DOI: 10.1002/jbmr.5650110417

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  9 in total

1.  A case of hepatitis C-associated osteosclerosis that was improved with the combination therapy of peginterferon alfa-2b and ribavirin.

Authors:  Satoshi Shakado; Yuko Akehi; Kaoru Yotsumoto; Atsushi Fukunaga; Shizuka Kuno; Takashi Tanaka; Kunitoshi Sakurai; Hideyuki Iwashita; Shuichi Ueda; Genryu Hirano; Keiji Yokoyama; Daisuke Morihara; Shinya Nishizawa; Masaharu Sakamoto; Akira Anan; Yasuaki Takeyama; Makoto Irie; Kaoru Iwata; Tetsuro Sohda; Shotaro Sakisaka
Journal:  Clin J Gastroenterol       Date:  2011-06-10

2.  Investigation of the relation between bone mass density and serum preptin levels in pre- and postmenopausal women.

Authors:  Saeed Nazari Soltan Aahmad; Sajjad Nourollahi; Faranak Kazerouni; Nahid Kianmehr; Hamed Hajipour; Davoud Sanajou; Vahid Hosseini
Journal:  J Bone Miner Metab       Date:  2017-11-13       Impact factor: 2.626

3.  Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults.

Authors:  S Khosla; A A Hassoun; B K Baker; F Liu; N N Zein; M P Whyte; C A Reasner; T B Nippoldt; R D Tiegs; R L Hintz; C A Conover
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

4.  An uncommon cause of acquired osteosclerosis in adults: hepatitis C-associated osteosclerosis.

Authors:  Narendranath Epperla; Fergus E McKiernan
Journal:  Skeletal Radiol       Date:  2014-04-10       Impact factor: 2.199

5.  OPG/RANKL system imbalance in a case of hepatitis C-associated osteosclerosis: the pathogenetic key?

Authors:  Paolo Manganelli; Nicola Giuliani; Pieranna Fietta; Cristina Mancini; Mirca Lazzaretti; Angela Pollini; Federico Quaini; Mario Pedrazzoni
Journal:  Clin Rheumatol       Date:  2004-12-04       Impact factor: 2.980

6.  Hepatitis C-associated osteosclerosis (HCAO): report of a new case with involvement of the OPG/RANKL system.

Authors:  C E Fiore; S Riccobene; R Mangiafico; F Santoro; P Pennisi
Journal:  Osteoporos Int       Date:  2005-06-28       Impact factor: 4.507

7.  Hepatitis C-Associated Osteosclerosis: Improvement After Treatment with Sofosbuvir, Daclatasvir, and Ibandronate: Case Report and Literature Review.

Authors:  Maria Carolina de Camargo Vieira; Wagner Rodrigo Brida Gonçalves; Ricardo Ayello Guerra; Fabiana Siroma Callegaro; Marise Lazaretti-Castro; Sergio Setsuo Maeda
Journal:  Calcif Tissue Int       Date:  2021-02-22       Impact factor: 4.333

8.  Hepatitis C-associated osteosclerosis: a case report.

Authors:  Kara M Schwartz; John A Skinner
Journal:  Skeletal Radiol       Date:  2008-04-15       Impact factor: 2.199

Review 9.  Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management.

Authors:  Celia L Gregson; Sarah A Hardcastle; Cyrus Cooper; Jonathan H Tobias
Journal:  Rheumatology (Oxford)       Date:  2013-02-27       Impact factor: 7.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.